In this research study, the investigators are looking at the effects of Meibomian Gland
Probing (MGP) versus a sham (fake) procedure in patients with refractory MGD who have already
tried traditional management with no success in resolving their clinical signs (as seen by
their ophthalmologist) or their symptoms.
The investigators are also evaluating the effects of using two (2) post-procedural medication
treatments: Blephamide or GenTeal PM Night-Time to determine if treatment after the MGP
procedure has an effect on its outcome.
Phase:
Phase 4
Details
Lead Sponsor:
Joseph B. Ciolino, MD Massachusetts Eye and Ear Infirmary